Last reviewed · How we verify
NCT03078153
Effect of Social Media Support and Financial Incentives on PrEP Adherence
NA trial testing Financial Incentive in Pre-Exposure Prophylaxis in 57 participants. Completed in 15 December 2020.
15 December 2020
Quick facts
| Lead sponsor | George Washington University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 57 |
| Start date | 1 April 2017 |
| Primary completion | 15 December 2020 |
| Estimated completion | 15 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Financial Incentive
- Social Media Group
Conditions studied
- Pre-Exposure Prophylaxis — all drugs for Pre-Exposure Prophylaxis →
Sponsor
George Washington University
Who can join
Adults 18 to 24, male only, with Pre-Exposure Prophylaxis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population.
Petkovic J, Duench S, Trawin J, Dewidar O, et al · · 2021 · cited 78× · PMID 34057201 · DOI 10.1002/14651858.cd012932.pub2
Verify or expand the search:
- PubMed search for NCT03078153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Financial Incentive
Trials testing the same drug.
- NCT07218120 — In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy · NA · recruiting
- NCT06300242 — Incentives for Influenza Vaccination · NA · completed
- NCT06234371 — Financial Incentives for Veteran Therapy Completion · NA · enrolling by invitation
- NCT06133816 — Lung Cancer Screening Eligibility Assessment · NA · completed
- NCT05648773 — COVID-19 Booster Incentives · NA · completed
Other recruiting trials for Pre-Exposure Prophylaxis
Currently open trials in the same condition.
- NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
- NCT06576648 — Thailand HIV and Stigma Reduction Study · NA · recruiting
- NCT05929521 — Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero · EARLY_PHASE1 · active not recruiting
- NCT06415357 — Zambia Healthy Choices Project for Emerging Adults Living With HIV · NA · active not recruiting
- NCT05262426 — Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults · NA · active not recruiting
Other George Washington University trials
Trials by the same sponsor.
- NCT07279129 — Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · not yet recruiting
- NCT07524309 — Self-Help Plus Pilot Study, Colombia: Train2Care · NA · not yet recruiting
- NCT07249008 — NSS Grocery Store Brazil · NA · recruiting
- NCT07000513 — HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST L · Phase 4 · not yet recruiting
- NCT07079306 — ChatGPT-Supported Text Messaging Program for Smoking Cessation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03078153 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by George Washington University
- Last refreshed: 2 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03078153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing